Instant Access with secure payment processing: $235 / One Month $975 / One Year Need an invoice? Group rate? Contact admin@DrugPatentWatch.com

Listing of Drug Product Information by Patent Expiration - 2012

Range: 1 - 5

Applicant Tradename Generic Name NDA Approval Date Type Patent Number Patent Expiration Patented / Exclusive Use Bracco MULTIHANCE gadobenate dimeglumine 021357 Nov 23, 2004 RX 4,916,246 Apr 10, 2012 Bracco MULTIHANCE MULTIPACK gadobenate dimeglumine 021358 Nov 23, 2004 RX 4,916,246 Apr 10, 2012 Novartis LESCOL fluvastatin sodium 020261 Dec 31, 1993 RX 5,354,772 Apr 11, 2012 Novartis LESCOL XL fluvastatin sodium 021192 Oct 6, 2000 RX 5,354,772 Apr 11, 2012 Eisai Medcl Res TARGRETIN bexarotene 021055 Dec 29, 1999 RX 6,043,279 Apr 22, 2012 TREATMENT OF CUTANEOUS MANIFESTATIONS OF CUTANEIOUS T-CELL LYMPHOMA IN PATIENTS WHO ARE REFRACTORY TO AT LEAST ONE PRIOR SYSTEMIC THERAPY

 Complete access available with subscription